Joe Kiani

Founder, Chairman, and CEO
Masimo Corporation (

Joe Kiani runs one of the world's most admired medical technology companies, is an inventor of world-changing noninvasive patient monitoring devices, a trusted voice for patient safety and care, and a convention-breaking maverick.

As the founder, Chairman, and CEO of Masimo Corporation, a global medical technology innovator credited with revolutionizing pulse oximetry and noninvasive patient monitoring, Mr. Kiani has been a beacon for patient safety and innovation in healthcare for more than 20 years.  Convinced that the use of adaptive signal processing could solve the problems of motion artifact and signal noise that plagued pulse oximetry—widely recognized as the 5th vital sign—he founded Masimo in 1989 to improve the accuracy of noninvasive patient monitoring.

Under his leadership, Masimo has grown from a “garage start up” into a successful publicly traded company (NASDAQ:  MASI) employing over 2,500 people worldwide and providing its market-leading measure-through motion and low perfusion pulse oximetry technology to leading OEM patient monitoring manufacturers spanning the globe, such as Atom, Drager, GE Medical, Medtronic, Mindray, Philips, Spacelabs, and Zoll. 

Today, Masimo is an innovative powerhouse delivering key noninvasive medical breakthroughs, including: Masimo SET®—the first Measure-Through Motion and Low Perfusion pulse oximetry technology proven to dramatically reduce ROP and improve the detection of CHD in newborns; Masimo Rainbow SET® Pulse CO-Oximetry™—the first noninvasive blood constituent monitoring platform to measure multiple blood constituents that previously required invasive procedures and help reduce risky blood transfusions; Masimo Patient SafetyNet™—the first remote monitoring and wireless clinician notification system designed to help hospitals improve patient safety and clinical outcomes by dramatically decreasing rescue events and costly ICU transfers; and Masimo Rainbow SET® Acoustic MonitoringTM—the first noninvasive and continuous acoustic respiration rate (RRaTM) monitoring technology.

Since 1989, Mr. Kiani and Masimo have helped to solve the "unsolvable" problems plaguing patient monitoring while building a substantial intellectual property portfolio with over 575 issued and pending patents worldwide. But his journey is more reminiscent of a David & Goliath story, complete with almost insurmountable obstacles and challenges, rather than an overnight success.  From taking on the most powerful healthcare GPOs (group purchasing organizations) in early 2000 and becoming a catalyst for nationwide change ( to taking on the goliath of the oximetry market for patent infringement of Masimo's game-changing technology (, Mr. Kiani and his company, Masimo, have fought long and hard to ensure that "doing what is best for patient care" is our nation's priority.  In the process, he and Masimo have become a modern day "triumph of the underdog" example of the American Dream, working to make sure other inventors have the opportunities he had.

Mr. Kiani’s dream of transforming patient care still thrives today as he works with legislators in Washington D.C. to effect public policy that supports innovation and promotes good healthcare decisions.  In 2010, he created the Masimo Foundation for Ethics, Innovation and Competition in Healthcare to encourage and promote activities, programs, and research opportunities that improve patient safety and deliver advanced healthcare worldwide—fostering access to innovative medical solutions for those who may not otherwise benefit from their lifesaving capabilities.  And in 2011 he founded the Masimo Political Action Committee to spotlight the important issues that will shape healthcare policy.

Mr. Kiani believes in turning yesterday's impossibilities into tomorrow's possibilities and challenging the status quo to move it forward.  This is exactly what he and his company, Masimo, have done and are continuing to do, and his passion is to share this insight, knowledge, and the indomitable spirit of a true innovator to improve healthcare for Americans and patients around the world.